title: High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
authors.affiliation: Liver Transplant Unit, Hôpital Henri Mondor-Université Paris XII, Créteil, France.
authors.forename: D
authors.initials: D
authors.lastname: Cherqui
authors.forename: C
authors.initials: C
authors.lastname: Duvoux
authors.forename: A
authors.initials: A
authors.lastname: Salvat
authors.forename: J Y
authors.initials: JY
authors.lastname: Lauzet
authors.forename: J M
authors.initials: JM
authors.lastname: Metreau
authors.forename: M
authors.initials: M
authors.lastname: Julien
authors.forename: P L
authors.initials: PL
authors.lastname: Fagniez
authors.forename: D
authors.initials: D
authors.lastname: Dhumeaux
mesh_terms: D000208:Acute Disease; D001379:Azathioprine / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001707:Biopsy, Needle; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000502:physiology; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011446:Prospective Studies; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D016853:Muromonab-CD3; D013256:Steroids; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D001663:Bilirubin; D008775:Methylprednisolone